Cargando…

Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model

BACKGROUND: Fusobacterium nucleatum (F. nucleatum) has long been known to cause opportunistic infections and has recently been implicated in colorectal cancer (CRC), which has attracted broad attention. However, the mechanism by which it is involved in CRC development is not fully understood. AIM: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Na, Feng, Yu-Qing, Lyu, Na, Wang, Di, Yu, Wei-Dong, Hu, Yong-Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150058/
https://www.ncbi.nlm.nih.gov/pubmed/35664967
http://dx.doi.org/10.3748/wjg.v28.i18.1981
_version_ 1784717343479300096
author Wu, Na
Feng, Yu-Qing
Lyu, Na
Wang, Di
Yu, Wei-Dong
Hu, Yong-Fei
author_facet Wu, Na
Feng, Yu-Qing
Lyu, Na
Wang, Di
Yu, Wei-Dong
Hu, Yong-Fei
author_sort Wu, Na
collection PubMed
description BACKGROUND: Fusobacterium nucleatum (F. nucleatum) has long been known to cause opportunistic infections and has recently been implicated in colorectal cancer (CRC), which has attracted broad attention. However, the mechanism by which it is involved in CRC development is not fully understood. AIM: To explore its potential causative role in CRC development, we evaluated the colon pathology, mucosa barrier, colon microbiota and host transcriptome profile after F. nucleatum infection in an azoxymethane/dextran sulfate sodium salt (AOM/DSS) mouse model. METHODS: Three groups of mice were compared to reveal the differences, i.e., the control, AOM/DSS-induced CRC and AOM/DSS-FUSO infection groups. RESULTS: Both the AOM/DSS and AOM/DSS-FUSO groups exhibited a significantly reduced body weight and increased tumor numbers than the control group, and AOM/DSS mice with F. nucleatum infection showed the highest tumor formation ratio among the three groups. Moreover, the colon pathology was the most serious in the AOM/DSS-FUSO group. We found that the structure of the colon microbiota changed considerably after F. nucleatum infection; striking differences in mucosal microbial population patterns were observed between the AOM/DSS-FUSO and AOM/DSS groups, and inflammation-inducing bacteria were enriched in the mucosal microbiota in the AOM/DSS-FUSO group. By comparing intestinal transcriptomics data from AOM vs AOM/DSS-FUSO mice, we showed that transcriptional activity was strongly affected by dysbiosis of the gut microbiota. The most microbiota-sensitive genes were oncogenes in the intestine, and the cyclic adenosine monophosphate signaling pathway, neuroactive ligand–receptor interaction, PPAR signaling pathway, retinol metabolism, mineral absorption and drug metabolism were highly enriched in the AOM/DSS-FUSO group. Additionally, we showed that microbial dysbiosis driven by F. nucleatum infection enriched eight taxa belonging to Proteobacteria, which correlates with increased expression of oncogenic genes. CONCLUSION: Our study demonstrated that F. nucleatum infection altered the colon mucosal microbiota by enriching pathogens related to the development of CRC, providing new insights into the role of F. nucleatum in the oncogenic microbial environment of the colon.
format Online
Article
Text
id pubmed-9150058
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-91500582022-06-04 Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model Wu, Na Feng, Yu-Qing Lyu, Na Wang, Di Yu, Wei-Dong Hu, Yong-Fei World J Gastroenterol Basic Study BACKGROUND: Fusobacterium nucleatum (F. nucleatum) has long been known to cause opportunistic infections and has recently been implicated in colorectal cancer (CRC), which has attracted broad attention. However, the mechanism by which it is involved in CRC development is not fully understood. AIM: To explore its potential causative role in CRC development, we evaluated the colon pathology, mucosa barrier, colon microbiota and host transcriptome profile after F. nucleatum infection in an azoxymethane/dextran sulfate sodium salt (AOM/DSS) mouse model. METHODS: Three groups of mice were compared to reveal the differences, i.e., the control, AOM/DSS-induced CRC and AOM/DSS-FUSO infection groups. RESULTS: Both the AOM/DSS and AOM/DSS-FUSO groups exhibited a significantly reduced body weight and increased tumor numbers than the control group, and AOM/DSS mice with F. nucleatum infection showed the highest tumor formation ratio among the three groups. Moreover, the colon pathology was the most serious in the AOM/DSS-FUSO group. We found that the structure of the colon microbiota changed considerably after F. nucleatum infection; striking differences in mucosal microbial population patterns were observed between the AOM/DSS-FUSO and AOM/DSS groups, and inflammation-inducing bacteria were enriched in the mucosal microbiota in the AOM/DSS-FUSO group. By comparing intestinal transcriptomics data from AOM vs AOM/DSS-FUSO mice, we showed that transcriptional activity was strongly affected by dysbiosis of the gut microbiota. The most microbiota-sensitive genes were oncogenes in the intestine, and the cyclic adenosine monophosphate signaling pathway, neuroactive ligand–receptor interaction, PPAR signaling pathway, retinol metabolism, mineral absorption and drug metabolism were highly enriched in the AOM/DSS-FUSO group. Additionally, we showed that microbial dysbiosis driven by F. nucleatum infection enriched eight taxa belonging to Proteobacteria, which correlates with increased expression of oncogenic genes. CONCLUSION: Our study demonstrated that F. nucleatum infection altered the colon mucosal microbiota by enriching pathogens related to the development of CRC, providing new insights into the role of F. nucleatum in the oncogenic microbial environment of the colon. Baishideng Publishing Group Inc 2022-05-14 2022-05-14 /pmc/articles/PMC9150058/ /pubmed/35664967 http://dx.doi.org/10.3748/wjg.v28.i18.1981 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Basic Study
Wu, Na
Feng, Yu-Qing
Lyu, Na
Wang, Di
Yu, Wei-Dong
Hu, Yong-Fei
Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model
title Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model
title_full Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model
title_fullStr Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model
title_full_unstemmed Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model
title_short Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model
title_sort fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model
topic Basic Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150058/
https://www.ncbi.nlm.nih.gov/pubmed/35664967
http://dx.doi.org/10.3748/wjg.v28.i18.1981
work_keys_str_mv AT wuna fusobacteriumnucleatumpromotescoloncancerprogressionbychangingthemucosalmicrobiotaandcolontranscriptomeinamousemodel
AT fengyuqing fusobacteriumnucleatumpromotescoloncancerprogressionbychangingthemucosalmicrobiotaandcolontranscriptomeinamousemodel
AT lyuna fusobacteriumnucleatumpromotescoloncancerprogressionbychangingthemucosalmicrobiotaandcolontranscriptomeinamousemodel
AT wangdi fusobacteriumnucleatumpromotescoloncancerprogressionbychangingthemucosalmicrobiotaandcolontranscriptomeinamousemodel
AT yuweidong fusobacteriumnucleatumpromotescoloncancerprogressionbychangingthemucosalmicrobiotaandcolontranscriptomeinamousemodel
AT huyongfei fusobacteriumnucleatumpromotescoloncancerprogressionbychangingthemucosalmicrobiotaandcolontranscriptomeinamousemodel